Hester Biosciences Ltd share price logo

Hester Biosciences Share Price

NSE: HESTERBIO

BSE: 524669

Small Cap

Healthcare Sector

₹1586.60

+2.90

(+0.18%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Hester Biosciences Stock Performance

as on December 26, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,576.2
    ₹1,597
    downward going graph

    0.66%

    Downside

    0.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,242.95
    ₹2,496.5
    downward going graph

    21.66%

    Downside

    57.35%

    Upside

    downward going graph

Hester Biosciences share price movements today

Previous Close
₹1,583.70
Open
₹1,587.90
Volume
1,354.00
Upper Circuit
₹1,900.40
Lower Circuit
₹1,267.00
Day's Low - High
₹1,576.2 - ₹1,597
52 Week Low - High
₹1,242.95 - ₹2,496.5

Hester Biosciences Historical Returns

1 Month Return
-3.59 %
3 Month Return
-17.34 %
1 Year Return
-33.85 %
3 Year Return
-12.01 %
5 Year Return
-7.79 %

Hester Biosciences Fundamentals

as on December 26, 2025 at 4:01 pm IST

Market Cap

₹1,349.70 Cr

Return on Equity (ROE)

9.77

PE Ratio (TTM)

30.27

Return on capital employed (ROCE)

9.47

Industry PE ratio

41.99

Beta (LTM)

0.7

P/B Ratio

3.15

Dividend Yield

0.56

PEG Ratio

1.41

Quarterly Earnings Growth YOY

70.8

EPS (TTM)

33.89

Sector

Pharmaceuticals

Book Value

369.41

Technical Analysis

Bearish

View Technical Analysis

Hester Biosciences Stock Valuation

as on December 26, 2025 at 4:01 pm IST

Hester Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (19.52x)

March 23, 2020

Today (30.27x)

December 26, 2025

Industry (41.99x)

December 26, 2025

Highest (124.52x)

July 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 30.27x

Hester Biosciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hester Biosciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,349.70-1.56%0.7428311
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA49.13119.71%0.00-1NA
Themis Medicare Ltd image
Themis Medicare Ltd
NA935.3734.75%0.5929405
Accent Microcell Ltd image
Accent Microcell Ltd
NA764.650.24%0.0033264
Vineet Laboratories Ltd image
Vineet Laboratories Ltd
NA73.18-3.51%0.00-2175
See all

Hester Biosciences Share Price Target

Get share price movements and forecasts by analysts on Hester Biosciences.

Source: S&P Global Market Intelligence

Hester Biosciences Stock’s Investor Sentiment and Interest

Search interest for Hester Biosciences Ltd Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-24% versus previous 30 day period

Hester Biosciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
74.94
67.3
87.85
70.46
66.98
79.26
82.27
83.69
63.22
81.93
84.11
70.97
Other Income
6.37
3.49
2.52
5.91
2.2
4.63
2.09
2.8
8.78
-5.64
3.37
11.88
Total Income
81.31
70.78
90.37
76.36
69.18
83.88
84.35
86.49
72
76.29
87.47
82.85
Expenses
56.19
55.62
73.49
57.24
56.83
63.33
64.62
64.53
58.16
62.74
61.29
59.25
Operating Profit
18.75
11.68
14.36
13.22
10.15
15.93
17.65
19.16
5.06
19.19
22.82
11.72
Operating Profit Margin %
25.02%
17.36%
16.35%
18.76%
15.15%
20.1%
21.45%
22.89%
8%
23.42%
27.13%
16.51%
Profit Before Interest, Tax and Depreciation
25.13
15.16
16.88
19.12
12.35
20.55
19.74
21.96
13.85
13.54
26.18
23.6
Interest
3.89
1.37
2.57
8.08
2.19
6.94
5.01
5.89
-3.81
5.62
1.81
2.21
Depreciation
5.24
5.37
5.4
4.28
3.75
3.74
4.13
4.2
4.29
4.18
4.18
4.35
Profit Before Tax
16
8.42
8.91
6.76
6.41
9.87
10.6
11.87
13.37
3.74
20.19
17.04
Tax Paid
3.84
2.71
2.2
2.72
2.4
3.47
3.11
3.48
1.96
2.2
2.9
2.71
Profit After Tax
12.16
5.71
6.71
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
14.33
Total Net profit including share of profit / Loss from associate company
12.16
5.71
6.71
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
14.33
EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
Actual EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
Adjusted EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
Diluted EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85

Hester Biosciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
121.02
132.6
178.07
183.27
214.33
235.01
266.09
304.55
311.1
Other Income
0.42
2.55
7.21
6.37
4.68
14.16
19.56
15.25
8.02
Total Income
123.53
138.49
185.28
189.63
219.02
249.17
285.65
319.79
319.13
Expenses
82.09
88.68
110.03
127.87
149
175.02
215.48
250.89
250.05
Operating Profit
38.93
43.92
68.04
55.4
65.33
59.99
50.61
53.66
61.05
Operating Profit Margin %
32.17%
33.12%
38.21%
30.23%
30.48%
25.53%
19.02%
17.62%
19.62%
Profit Before Interest, Tax and Depreciation
41.44
49.82
75.25
61.77
70.02
74.15
70.17
68.9
69.08
Interest
3.5
4.04
6.63
7.37
6.6
4.06
9.32
19.78
12.7
Depreciation
7
9.66
11.76
13.07
13.31
16.58
20.7
17.17
16.8
Profit Before Tax
30.94
36.12
56.86
41.33
50.11
53.51
40.15
31.95
39.58
Tax Paid
8.14
13.06
16.16
10.33
15.41
14.01
12.12
10.79
10.74
Profit After Tax
22.79
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
Total Net profit including share of profit / Loss from associate company
22.79
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Actual EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Adjusted EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Diluted EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89

Hester Biosciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
18.85
34.8
38.02
46.71
36.77
58.05
8.71
23.6
48.18
64.51
Cash Flow from Investing Activities
0.59
0.06
-2.82
1.61
0.86
-1.35
-21.07
0.82
1.95
1.08
Cash Flow from Financing Activities
-6.69
1.83
-11.08
2.64
18.74
-18.23
111.55
41.75
-26.1
-51.72
Net Cash Flow
-1.14
6.45
1.15
28.32
-17.12
-2.26
3.48
-11.59
-0.36
-6.72

Mutual Funds that own Hester Biosciences Stock

Check out the Mutual Funds with significant holdings in Hester Biosciences.

Hester Biosciences Corporate Actions

View detailed summary of the earnings and dividend history of Hester Biosciences.

  • Hester Biosciences Ltd Earnings Results

    Hester Biosciences Ltd’s net profit jumped 76.22% since last year same period to ₹14.45Cr in the Q2 2025-2026. On a quarterly growth basis, Hester Biosciences Ltd has generated -12.1% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Hester Biosciences Ltd Dividends May,2025

    In the quarter ending March 2025, Hester Biosciences Ltd has declared dividend of ₹7.00 per share on 09 May 2025 - translating a dividend yield of 0.82%.

    Read More about Dividends

Indices Featuring Hester Biosciences Stock

Check stock indices that include Hester Biosciences.

BSE Healthcare

₹43,870.76

-0.36 (▲-159.61%)

BSE Small-Cap

₹51,318.68

-0.34 (▲-174.94%)

Insights on Hester Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.73% to 45.74% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.04% to 0.53% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 144.3% return, outperforming this stock by 160.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 53.73% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 12.1% return, outperforming this stock by 46.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, HESTERBIO stock has moved down by -17.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 16.44 Cr → 14.45 Cr (in ₹), with an average decrease of 12.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 87.47 Cr → 82.85 Cr (in ₹), with an average decrease of 5.3% per quarter

About Hester Biosciences Ltd

Hester Pharmaceutical (HPL), established as a private limited company in April 1987 and transitioning to a public limited company in November of 1993, offers a range of veterinary and pharmaceutical products, such as animal health products, poultry vaccines, and laboratory kits and reagents. Furthermore, it markets the veterinary products of up to 10 international companies, including Ghen Corporation (Japan), Maine Biological Laboratories (US), Idexx Corporation (US), and Biogal Galed Laboratories (Israel). Entering the production of veterinary vaccines in vials, HPL also has technical collaborations with Maine Biological Laboratories and Ghen Corporation, and has since received licenses for producing an additional 10 poultry vaccines. To facilitate increased production, HPL has signed a manufacturing agreement with Sinsui Inc. for the production of additional poultry vaccines. Overall, HPL has continued to grow in the years since it was first established.

Revenue: ₹70.97Cr as on September 2025 (Q2 FY26)
Net Profit: ₹14.33Cr as on September 2025 (Q2 FY26)
Listing date: 13 Mar, 2015
OrganisationHester Biosciences Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Hester Biosciences share price today?

Hester Biosciences share price today stands at ₹1586.6 as on at the close of the market. Hester Biosciences share today touched a day high of ₹1597 and a low of ₹1576.2.

What is the 52 week high and 52 week low range for Hester Biosciences share?

Hester Biosciences touched a 52 week high of ₹2496.5 and a 52 week low of ₹1242.95. Hester Biosciences share price today i.e. is closed at ₹1586.6, which is -36.45% down from its 52 week high and 27.65% up from its 52 week low.

What is Hester Biosciences's market capitalisation today?

Hester Biosciences market capitalisation is ₹1,349.70 Cr as on .

How to buy Hester Biosciences shares?

To buy Hester Biosciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for HESTERBIO or Hester Biosciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Hester Biosciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Hester Biosciences trading volume today?

Hester Biosciences trading volume is 1,354.00 as on . This means that 1,354.00 shares of Hester Biosciences were bought and sold on the stock market during today's trading session.